AzTrials
AzTrials

Obstructive Sleep ApneaASCOTNCT07086612

Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and Transverse Orthodontic Deficiency in Children

A study testing over nigtht ventilatory polysomnograph test in people with Obstructive Sleep Apnea and Transverse Maxillary Deficiency, run by Fondation Hôpital Saint-Joseph at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

OSAHS (Obstructive Sleep Apnea Hypopnea Syndrome) in children is a frequent respiratory disorder, whose prevalence is estimated at between 1.2 and 5.7%, and which, if left untreated, can cause severe medical complications. This prevalence tends to be underestimated. Read more about this study

Who is it for?
Ages 6 to 16 years
What is being tested?
over nigtht ventilatory polysomnograph test
Could I receive a placebo?
No, everyone receives an active treatment
How many people
102 participants
Where
1 siteFrance
Study dates
6 Nov 2025to 30 Sep 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Patient aged between 6 and 16 years
  • Patients with a transverse orthodontic deficiency (group "CAS")
  • Patients with another type of orthodontic deficiency (group "CONTROL") such as tooth rotation, crowding, mild Angle Class II or Class III dental occlusion
  • Patient who has given free, informed oral consent
  • Patient whose legal representatives have given their free written consent
  • Patient affiliated with a health insurance scheme

Who cannot join

  • Patients refusing to participate in the study
  • Patients whose legal representatives refuse to participate in the study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Service d'orthopédie dento-cranio-maxillo faciale

    Rouen, 7600

    Perrine KRUK, MD, +3344127963, kruk.perrine@live.fr

    Recruiting

Other trials in France

About this study

OSAHS (Obstructive Sleep Apnea Hypopnea Syndrome) in children is a frequent respiratory disorder, whose prevalence is estimated at between 1.2 and 5.7%, and which, if left untreated, can cause severe medical complications. This prevalence tends to be underestimated. Diagnosis is made following a clinical examination noting the presence of characteristic clinical and polysomnographic criteria. Multidisciplinary management has been widely described in the literature, and various therapeutic options have been indicated. Rapid maxillary expansion has proved highly effective in the treatment of this condition. This syndrome is a real public health problem and must be diagnosed as early as possible. Through our research, we would like to study whether there is a causal link between an orthodontic problem of the transverse direction and the presence of SAHOS in children. In other words, we would like to assess whether children who clinically present an orthodontic deficiency of their transverse dimension are more likely to develop SAHOS than children without this deficit. If this proves to be true, then a new clinical sign could enable certain healthcare professionals to detect this syndrome early, and be able to refer patients to physicians as soon as possible.

Being tested
over nigtht ventilatory polysomnograph test
Medical subject headings
Sleep Apnea, Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • over nigtht ventilatory polysomnograph testDiagnostic test

    Every patient will have an overnight polysomnography test.

Study groups in NCT07086612
Study groupRoleWhat they receive
transverse deficiency maxillaExperimentalpatient with transverse deficiency maxilla
Receives: Diagnostic Test: over nigtht ventilatory polysomnograph test
other type of maxilla deficiencyOtherpatient with other type maxilla deficiency
Receives: Diagnostic Test: over nigtht ventilatory polysomnograph test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. study whether children with a transverse orthodontic deficiency have a higher risk of developing Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) compared to those without this deficiency,

    compare the proportion of children with an Apnea-Hypopnea Index (AHI) >1, , based on the presence or absence of a transverse deficiency." AHI is evaluated with the polysomnography exam

    Measured: 1 months after enrollement

Secondary outcomes (4)
  1. study whether all children with a transverse orthodontic deficiency systematically have Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)

    distribution of Apnea-Hypopnea Index (AHI) values among these children

    Measured: one month after enrollement

  2. Investigate a link between the severity of this transverse deficiency and the severity of OSAHS.

    Distribution of AHI values among children based on the extent of the transverse deficiency. Three groups will be formed for the transverse deficiency : one for pure endognathies, one for endoalveolies, and one for crossbite occlusions.".

    AHI is evaluated with the polysomnography exam.

    Measured: 1month after enrollement

  3. impact of hteSeverity of transferse deficiency on the snoring events frequency.

    Average number of snoring events per hour based on the severity of the transverse deficiency. Three groups for the transverse defficiency will be formed: one for pure endognathies, one for endoalveolies, and one for crossbite occlusions.

    Number of snoring event will be mesured by the polysomnography exam.

    Measured: 1months after enrollement

  4. diagnostic value of the sleep disorder screening scale for children aged 4 to 16 years

    comparison of the sleep disorder screening scale results with the results of the polysomnography exam.

    Measured: 1month after enrollement

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2025
  2. Study start6 Nov 2025
  3. Primary completion1 Sep 2026 (estimated)
  4. Study completion30 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
102 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07086612
Sponsor's protocol ID
761-ASCOT
Other IDs
2025-A00478-41
Acronym
ASCOT
Status last verified
Mar 2026
First submitted
18 Jul 2025
Last updated
30 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing over nigtht ventilatory polysomnograph test in people with Obstructive Sleep Apnea and Transverse Maxillary Deficiency, run by Fondation Hôpital Saint-Joseph at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

study whether children with a transverse orthodontic deficiency have a higher risk of developing Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) compared to those without this deficiency, (time frame: 1 months after enrollement). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in